Migraine – Medical Marijuana

The endocannabinoid system and migraine

By admin| 2016-07-07T07:13:03+01:00 July 7th, 2016|

Endocannabinoids in the Brainstem Modulate Dural Trigeminovascular Nociceptive Traffic via CB1 and “Triptan” Receptors- Implications in Migraine

By admin| 2016-07-07T07:12:27+01:00 July 7th, 2016|

Effects of anandamide in migraine- data from an animal model

By admin| 2016-07-07T07:11:52+01:00 July 7th, 2016|

Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache- What a Long Strange Trip It’s Been

By admin| 2016-07-07T07:11:13+01:00 July 7th, 2016|

Clinical endocannabinoid deficiency (CECD) revisited- Can this concept explain the therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions

By admin| 2016-07-07T07:07:15+01:00 July 7th, 2016|

Clinical Endocannabinoid Deficiency (CECD)- Can this Concept Explain Therapeutic Benefits of Cannabis in Migraine, Fibromyalgia, Irritable Bowel Syndrome and other Treatment-Resistant Conditions

By admin| 2016-07-07T07:06:39+01:00 July 7th, 2016|

Activation of CB2 receptors as a potential therapeutic target for migraine- evaluation in an animal model

By admin| 2016-07-07T07:05:56+01:00 July 7th, 2016|